Literature DB >> 7548902

Disease due to Mycobacterium kansasii in the Czech Republic: 1984-89.

J Kaustová1, M Chmelík, D Ettlová, V Hudec, H Lazarová, S Richtrová.   

Abstract

SETTING: Endemic area of North Moravia, Czech Republic.
OBJECTIVE: Evaluate the incidence of human disease due to Mycobacterium kansasii. The follow-up of some bacteriological and clinical features.
DESIGN: A retrospective analysis of M. kansasii patients.
RESULTS: M. kansasii was isolated from the sputum, tissue and other specimens obtained from 650 persons during the period 1984-89. In only 471 of them was this mycobacterium deemed to be the causative agent, predominantly of lung disease. The most typical radiographic finding in these patients was lung infiltration and/or thin-walled cavity.
CONCLUSION: As in previous years the highest incidence of disease remains in an endemic area of North Moravia. The effects of treatment in follow-up patients were influenced not only by the antituberculosis regimen but also by a high frequency of associated diseases. Sputum conversion within 30 days was not affected by the presence or absence of a cavity. Authors consider water to be the source of infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548902     DOI: 10.1016/s0962-8479(05)80006-1

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  10 in total

1.  Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

2.  Evaluation of a modified single-enzyme amplified-fragment length polymorphism technique for fingerprinting and differentiating of Mycobacterium kansasii type I isolates.

Authors:  Ayman Gaafar; M Josebe Unzaga; Ramón Cisterna; Felicitas Elena Clavo; Elena Urra; Rafael Ayarza; Gloria Martín
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

3.  Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics.

Authors:  Theodore K Marras; Mauli Mehta; Pamela Chedore; Kevin May; Mohammed Al Houqani; Frances Jamieson
Journal:  Lung       Date:  2010-04-11       Impact factor: 2.584

4.  Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies.

Authors:  F Alcaide; I Richter; C Bernasconi; B Springer; C Hagenau; R Schulze-Röbbecke; E Tortoli; R Martín; E C Böttger; A Telenti
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

5.  Treatment of Non-Tuberculous Mycobacterial Lung Disease.

Authors:  Julie V Philley; Mary Ann DeGroote; Jennifer R Honda; Michael M Chan; Shannon Kasperbauer; Nicholas D Walter; Edward D Chan
Journal:  Curr Treat Options Infect Dis       Date:  2016-10-11

6.  Infection of a Free-Living Wild Boar (Sus scrofa) with a Bacterium from the Mycobacterium kansasii Complex.

Authors:  Łukasz Radulski; Monika Krajewska-Wędzina; Marek Lipiec; Krzysztof Szulowski
Journal:  Animals (Basel)       Date:  2022-04-08       Impact factor: 3.231

7.  Short communication: subtyping of Mycobacterium kansasii by PCR-restriction enzyme analysis of the hsp65 gene.

Authors:  Zofia Bakuła; Aleksandra Safianowska; Magdalena Nowacka-Mazurek; Jacek Bielecki; Tomasz Jagielski
Journal:  Biomed Res Int       Date:  2013-12-22       Impact factor: 3.411

8.  Mycobacteria in water used for personal hygiene in heavy industry and collieries: a potential risk for employees.

Authors:  Vit Ulmann; Anna Kracalikova; Radka Dziedzinska
Journal:  Int J Environ Res Public Health       Date:  2015-03-04       Impact factor: 3.390

9.  Diagnosing MonoMAC Syndrome in GATA2 Germline Mutated Myelodysplastic Syndrome via Next-Generation Sequencing in a Patient with Refractory and Complex Infection: Case Report and Literature Review.

Authors:  Yingying Shen; Yuzhu Li; Hangchao Li; Qi Liu; Huijie Dong; Bo Wang; Baodong Ye; Shenyun Lin; Yiping Shen; Dijiong Wu
Journal:  Infect Drug Resist       Date:  2021-04-06       Impact factor: 4.003

10.  Socio-Economic and Environmental Factors Related to Spatial Differences in Human Non-Tuberculous Mycobacterial Diseases in the Czech Republic.

Authors:  Helena Modrá; Vít Ulmann; Jan Caha; Dana Hübelová; Ondřej Konečný; Jana Svobodová; Ross Tim Weston; Ivo Pavlík
Journal:  Int J Environ Res Public Health       Date:  2019-10-17       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.